Talphera Inc. (NASDAQ: TLPH) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TALPHERA INC.

Talphera Inc. (NASDAQ: TLPH)
Listen to this Section


$1.08
+0.0240 ( +2.26% ) 49.3K

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Clinical Trial Pipeline Stages


Drug Name Stage
DSUVIA (sufentanil)DetailsPost operative acute pain Approved
Nafamostat (Niyad™)DetailsMedical deviceBig Mover™Suspected Mover™Susp. Mover™ Phase 3
Zalviso US (sufentanil)DetailsPost operative acute pain Failed

Market Data


Open $1.08
Previous Close $1.06
Volume 49.3K
Market Cap $55.01M
Day Range $1.07 - $1.12
52 Week Range $0.38 - $1.57
Shares Outstanding 51.90M
Change % +2.26%
Net Change ▲ 0.0240
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2011
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -3,390,864.00

Date Type Amount Purchased Purchaser
2024-12-06 Buy 5000.00 Angotti Vincent J.
2024-12-02 Buy 5000.00 Angotti Vincent J.
2024-09-03 Buy 7260.00 Angotti Vincent J.
2024-06-24 Sale -2174.00 HOFFMAN STEPHEN J
2024-06-24 Sale -2174.00 ADAMS ADRIAN
2024-06-24 Sale -2174.00 WAN MARK A
2024-06-24 Sale -2174.00 Broadfoot Jill Marie
2024-06-24 Sale -2174.00 JAIN ABHINAV
2024-06-24 Sale -2174.00 Bozilenko Marina
2024-06-14 Buy 4126.00 Angotti Vincent J.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 61 Nov 12, 2025
8-k 8K-related 15 Nov 12, 2025
4 Insider transactions 1 Oct 24, 2025
8-k 8K-related 15 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
8-k 8K-related 13 Oct 22, 2025

Latest News